Search

Author/Creator Swanepoel, Robert

3. High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo. Issue 1 (December 2016)

Authors:
Mulangu, Sabue; Borchert, Matthias; Paweska, Janusz; Tshomba, Antoine; Afounde, Afongenda; Kulidri, Amayo; Swanepoel, Robert; Muyembe-Tamfum, Jean-Jacques; Van der Stuyft, Patrick
Journal:
BMC infectious diseases
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Neutralizing antibodies against Rift Valley fever virus in wild antelope in far northern KwaZulu‐Natal, South Africa, indicate recent virus circulation. Issue 3 (21st January 2020)

Authors:
Van den Bergh, Carien; Venter, Estelle H.; Swanepoel, Robert; Hanekom, Cathariné C.; Thompson, Peter N.
Journal:
Transboundary and emerging diseases
Issue:
Volume 67:Issue 3(2020)
Page Start:
1356
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile. (7th August 2020)

Authors:
Monath, Thomas P.; Kortekaas, Jeroen; Watts, Douglas M.; Christofferson, Rebecca C.; Desiree LaBeaud, Angelle; Gowen, Brian B; Peters, Clarence J.; Smith, Darci R.; Swanepoel, Robert; Morrill, John C.; Ksiazek, Thomas G.; Pittman, Phillip R; Nichol, Stuart T.; Bird, Brian H.; Bettinger, George
Journal:
Vaccine
Issue:
Volume 5(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗